Cite
HARVARD Citation
Fabbri, L. et al. (2016). Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD. Respiratory research. 17 (1), pp. 1-11. [Online].